Form 10 Explorer
10-Q
Quarterly Report
BIO KEY INTERNATIONAL INC

BKYI

NASDAQ

CIK: 1019034

File #: 1-13463

Period End: Mar 31, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
37 line items · 2 periods
XBRL
ItemMar 31, 2024Dec 31, 2023
ASSETS
Cash and cash equivalents
690,449511,400
Accounts receivable, net
701,7761,201,526
Due from factor
8,25099,320
Inventory
440,194445,740
Prepaid expenses and other
427,685364,171
Total current assets
2,268,3542,622,157
Equipment and leasehold improvements, net
198,238220,177
Capitalized contract costs, net
349,145229,806
Operating lease right-of-use assets
23,22036,905
Approximation
23,22036,905
Intangible assets, net
1,329,9851,407,990
Total non-current assets
1,900,5881,894,878
TOTAL ASSETS
4,168,9424,517,035
LIABILITIES
Accounts payable
1,212,0711,316,014
Accrued liabilities
1,189,5201,305,848
Government loan – BBVA Bank, current portion
135,835138,730
Deferred revenue, current
755,405414,968
Operating lease liabilities, current portion
23,79737,829
Total current liabilities
3,316,6283,213,389
Deferred revenue, long term
143,72728,296
Deferred tax liability
22,99822,998
Government loan – BBVA Bank – net of current portion
149,861188,787
Total non-current liabilities
316,586240,081
TOTAL LIABILITIES
3,633,2143,453,470
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 1,814,414 and 1,032,777 of $.0001 par value at March 31, 2024 and December 31, 2023, respectively
181103
Additional paid-in capital
126,092,496126,047,851
Accumulated other comprehensive loss
(39,454)22,821
Accumulated deficit
(125,517,495)(125,007,210)
TOTAL STOCKHOLDERS’ EQUITY
535,7281,063,565
Common Stock
181103
Additional Paid-in Capital
126,092,496126,047,851
AOCI Attributable to Parent
(39,454)22,821
Retained Earnings
(125,517,495)(125,007,210)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
4,168,9424,517,035